Incidence and prevention of ischemic stroke following myocardial infarction: Review of current literature

被引：19
作者：
Dutta, Monisha
Hanna, Elias
Das, Pranab
Steinhubl, Steven R.
机构：
[1] Univ Kentucky, Dept Neurol, Lexington, KY 40506 USA
[2] Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA
[3] Univ Kentucky, Linda & Jack Gill Heart Inst, Lexington, KY 40506 USA
来源：
CEREBROVASCULAR DISEASES | 2006年 / 22卷 / 5-6期
关键词：
myocardial infarction; stroke; anti-platelet therapy;
D O I：
10.1159/000094847
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Myocardial infarction is the leading cause of death today. With the fast progress in pharmacotherapy and revascularization technology, outcomes following a myocardial infarction have become very favorable. While most of the complications from a myocardial infarction can be adequately managed, thus leading to reduced mortality, stroke following a myocardial infarction remains a challenge even today, and can lead to potentially devastating complications. We discuss the incidence, pathophysiology, and management options of non-hemorrhagic stroke following a myocardial infarction. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码：331 / 339
页数：9
相关论文
共 60 条
  • [41] Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction
    Pedersen, OD
    Abildstrom, SZ
    Ottesen, MM
    Rask-Madsen, C
    Bagger, H
    Kober, L
    Torp-Pedersen, C
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (03) : 290 - 295
  • [42] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
    Pfeffer, MA
    McMurray, JJV
    Velazquez, EJ
    Rouleau, JL
    Kober, L
    Maggioni, AP
    Solomon, SD
    Swedberg, K
    Van de Werf, F
    White, H
    Leimberger, JD
    Henis, M
    Edwards, S
    Zelenkofske, S
    Sellers, MA
    Califf, RM
    Aylward, P
    Armstrong, P
    Barvik, S
    Belenkov, Y
    Dalby, A
    Diaz, R
    Drexler, H
    Ertl, G
    Francis, G
    Hampton, J
    Harsanyi, A
    Kvasnicka, J
    Mareev, V
    Marin-Neto, J
    Murin, J
    Myers, M
    Nordlander, R
    Opolski, G
    Soler-Soler, J
    Spac, J
    Stefenelli, T
    Sugrue, D
    Van Gilst, W
    Varshavsky, S
    Weaver, D
    Zannad, F
    Aguilar, D
    Alvarez, A
    Al-Taweel, M
    Anavekar, N
    Finn, P
    Lopez-Jimenez, F
    Mercier, R
    Lewis, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) : 1893 - 1906
  • [43] Antithrombotic therapy in patients undergoing percutaneous coronary intervention
    Popma, JJ
    Ohman, EM
    Weitz, J
    Lincoff, M
    Harrington, RA
    Berger, P
    [J]. CHEST, 2001, 119 (01) : 321S - 336S
  • [44] Acute myocardial infarction complicated by atrial fibrillation in the elderly - Prevalence and outcomes
    Rathore, SS
    Berger, AK
    Weinfurt, KP
    Schulman, KA
    Oetgen, WJ
    Gersh, BJ
    Solomon, AJ
    [J]. CIRCULATION, 2000, 101 (09) : 969 - 974
  • [45] Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)
    Rothwell, PM
    Coull, AJ
    Silver, LE
    Fairhead, JF
    Giles, MF
    Lovelock, CE
    Redgrave, JNE
    Bull, LM
    Welch, SJV
    Cuthbertson, FC
    Binney, LE
    Gutnikov, SA
    Anslow, P
    Banning, AP
    Mant, D
    Mehta, Z
    [J]. LANCET, 2005, 366 (9499) : 1773 - 1783
  • [46] Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
    Sabatine, MS
    Cannon, CP
    Gibson, CM
    Lopez-Sendon, JL
    Montalescot, G
    Theroux, P
    Claeys, MJ
    Cools, F
    Hill, KA
    Skene, AM
    McCabe, CH
    Braunwald, E
    Braunwald, E
    Cannon, C
    Sabatine, M
    McCabe, C
    McCagg, A
    Job, B
    Gaudin, C
    Thizon-de Gaulle, I
    Blumenthal, M
    Saini, R
    Delaet, I
    Townes, L
    Anhalt, D
    van Holder, K
    Skene, A
    Hill, K
    Braunwald, E
    Cannon, C
    Sabatine, M
    McCabe, C
    Job, B
    Gaudin, C
    Thizon-de Gaulle, I
    Blumenthal, M
    Saini, R
    Delaet, I
    Townes, L
    Skene, A
    Ardissino, D
    Aylward, P
    Bertrand, M
    Bode, C
    Budaj, A
    Claeys, M
    Dellborg, M
    Ferreira, R
    Gershlick, A
    Huber, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12) : 1179 - 1189
  • [47] Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics -: The PCI-CLARITY study
    Sabatine, MS
    Cannon, CP
    Gibson, CM
    López-Sendón, JL
    Montalescot, G
    Theroux, P
    Lewis, BS
    Murphy, SA
    McCabe, CH
    Braunwald, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (10): : 1224 - 1232
  • [48] A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
    Schomig, A
    Neumann, FJ
    Kastrati, A
    Schuhlen, H
    Blasini, R
    Hadamitzky, M
    Walter, H
    ZitzmannRoth, EM
    Richardt, G
    Alt, E
    Schmitt, C
    Ulm, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (17) : 1084 - 1089
  • [49] STAURT JC, 2005, AHA M DALL
  • [50] Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome -: A prospective cohort study from the register of information and knowledge about Swedish heart intensive care admissions (RIKS-HIA)
    Stenestrand, U
    Lindbäck, J
    Wallentin, L
    [J]. CIRCULATION, 2005, 112 (21) : 3225 - 3231
123456